Pro-resolving lipid mediators in sepsis and critical illness
- PMID: 31904604
- DOI: 10.1097/MCO.0000000000000633
Pro-resolving lipid mediators in sepsis and critical illness
Abstract
Purpose of review: Sepsis is a life-threatening condition caused by a dysregulated host response to infection that remains a huge clinical challenge. Recent evidence indicates that bioactive lipid mediators derived from polyunsaturated fatty acids termed specialized pro-resolving mediators (SPMs) are promising new candidates for treating critical illness.
Recent findings: We highlight herein the protective actions of SPMs in experimental sepsis, cardiac dysfunction, and also lung and cerebral injury, and discuss their mechanisms of action. We also emphasize that failed resolution responses and dysregulated SPM pathways may provide an explanation for the ongoing chronic inflammation in many diseases including chronic heart failure.
Summary: Importantly, monitoring plasma SPM profiles can predict patient outcomes in sepsis indicating their utility as new early biomarkers that may help stratify patients upon ICU admission.
References
-
- Dalli J, Serhan CN. Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology. Br J Pharmacol 2019; 176:1024–1037.
-
- Dalli J, Colas RA, Quintana C, et al. Human sepsis eicosanoid and proresolving lipid mediator temporal profiles: correlations with survival and clinical outcomes. Crit Care Med 2017; 45:58–68.
-
- Hao Y, Zheng H, Wang RH, et al. Maresin1 alleviates metabolic dysfunction in septic mice: a (1)H NMR-based metabolomics analysis. Mediators Inflamm 2019; 2019:2309175.
-
- Gu J, Luo L, Wang Q, et al. Maresin 1 attenuates mitochondrial dysfunction through the ALX/cAMP/ROS pathway in the cecal ligation and puncture mouse model and sepsis patients. Lab Invest 2018; 98:715–733.
-
- Zhuo Y, Zhang S, Li C, et al. Resolvin D1 promotes SIRT1 expression to counteract the activation of STAT3 and NF-kappaB in mice with septic-associated lung injury. Inflammation 2018; 41:1762–1771.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials